Clinical Studies & Research
Aesthetic Solutions is an active research center, partnering with pharmaceutical and medical device manufacturers to bring the latest treatments to our patients and advance safe, effective aesthetic treatments.
Glabellar Neuromodulator 2111-53
Status: Enrolling Now
We are currently enrolling for this study evaluating the safety and efficacy of a neuromodulator when used for the treatment of glabellar lines. Dr. Cox will be serving as principal investigator.
Platysma Bands Neuromodulator 2109-52
Status: Enrolling Now
We are currently enrolling for this study evaluating the safety and effectiveness of a neuromodulator in the platysma bands. Dr. Cox is serving as the principal investigator.
Nasolabial Folds Filler 2102-51
Status: Completed
Dr. Cox has completed work for this study evaluating the effectiveness of a filler in the nasolabial folds when injected with a needle and cannula. Dr. Cox has long been using cannulas for high-risk injection areas, and hopes to see the technique more widely used in the coming years.
Temple Filler 2005-50
Status: In Progress
We have finished enrollment for this study evaluating the effectiveness of a filler when used in the temples. Dr. Cox is serving as the principal investigator.
Crow’s Feet Neuromodulator 2002-49
Status: Completed
Dr. Cox has completed work as the principal investigator for this study evaluating the effectiveness of a new neuromodulator when used in the crow’s feet (around the eyes) area. This study began in February 2020 and ended in March 2021. We hope to see this product on the market soon!
Glabellar Neuromodulator 1904-48
Status: Completed
Dr. Cox has completed work on this study servings as the principal investigator. This study evaluated the effectiveness of a new neuromodulator when used in the glabellar (between the brows) area.
Body Contouring 1811-47
Status: Completed
Dr. Cox completed work as the principal investigator in this study “A Feasibility Study to Evaluate Electromagnetic Muscle Stimulation and CoolSculpting for Abdominal Contouring”. The study began in November 2018 and ended in April 2019.
Glabellar Neuromodulator 1811-46
Status: Completed
Dr. Cox completed work for this study “A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines” serving as the principal investigator.
Jawline Filler 1811-45
Status: Completed
Dr. Cox has completed work as the principal investigator for this multicenter, evaluator-blinded, randomized, parallel-group, controlled study of the safety and effectiveness of JUVÉDERM VOLUX™ XC injectable gel for restoring jawline definition. This study began in November 2018 and ended in April 2021.
Cheek Filler 1802-44
Status: Completed
Dr. Cox completed work as the principal investigator on this multicenter, single-blind, randomized, controlled study of the safety and effectiveness of JUVÉDERM
VOLUMA® XC injectable gel for cheek augmentation using a cannula. Dr. Cox has long been an advocate for the safety and effectiveness of injecting with the use of a cannula rather than just a needle in the mid-face. This study began in February of 2018 and finished in October of 2018.